Acasti Announces Third Quarter Results
Important progress made with FDA on CaPre® development pathway Amended IND application to commence bioavailability bridging study submitted Entered into licensing agreement with Neptune to market Onemia® LAVAL, Québec, Jan. 12, 2016 (GLOBE NEWSWIRE) -- …